Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription 20.05.2024 1 Aliment Pharmacol Ther 1 BMC Gastroenterol 1 Br J Surg 6 Clin Gastroenterol Hepatol 1 Clin Res Hepatol Gastroenterol 3 Dig Dis Sci 1 Gastroenterol Hepatol 1 Gut 4 Inflamm Bowel Dis 5 J Crohns Colitis 1 J Gastroenterol 1 Lancet 2 Lancet Gastroenterol Hepatol 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. PLOTKIN L, Buchuk R, Lujan R, Focht G, et al
   Enteral nutrition compared with corticosteroids in children with Crohn's disease: A long-term nationwide study from the epi-IIRN.
   Aliment Pharmacol Ther. 2024 May 14. doi: 10.1111/apt.18028.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

2. DZIEGIELEWSKI C, Gupta S, Begum J, Pugliese M, et al
   Clinical and health care utilization variables can predict 90-day hospital re-admission in adults with Crohn's disease for point of care risk evaluation.
   BMC Gastroenterol. 2024;24:172.
   PubMed         Abstract available
   
   

   
   Br J Surg

3. GIDDINGS HL, Yang PF, Steffens D, Solomon MJ, et al
   Influence of hospital-level and surgeon factors on the outcomes after ileo-anal pouch surgery for inflammatory bowel disease: systematic review.
   Br J Surg. 2024;111:znae088.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

4. FUMERY M, Caron B, Hebuterne X, Altwegg R, et al
   Long-term outcome of risankizumab in Crohn's disease: a real-world GETAID study.
   Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00423.
   PubMed         Abstract available
   
   
5. AGRAWAL M, Stordal K, Hansen AV, Ostensson M, et al
   Breastfeeding duration is not associated with offspring inflammatory bowel disease risk in three population-based birth cohorts.
   Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00416.
   PubMed         Abstract available
   
   
6. MOULTON CD, Young AH, Hart AL
   Targeting durable remission of fatigue in inflammatory bowel disease.
   Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00433.
   PubMed        
   
   
7. PUDIPEDDI A, Paramsothy S, Kariyawasam V, Paramsothy R, et al
   Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: a Randomized Controlled Trial.
   Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00426.
   PubMed         Abstract available
   
   
8. AXELRAD JE, Hashash JG, Itzkowitz SH
   AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients with Malignancy: Commentary.
   Clin Gastroenterol Hepatol. 2024 May 14:S1542-3565(24)00354.
   PubMed         Abstract available
   
   
9. XUE M, Leibovitzh H, Jingcheng S, Neustaeter A, et al
   Environmental Factors Associated with Risk of Crohn's Disease Development in the CCC-GEM Project.
   Clin Gastroenterol Hepatol. 2024 May 15:S1542-3565(24)00450.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

10. VERMEIRE S, Dubinsky MC, Rabizadeh S, Panetta JC, et al
    Forecasted Infliximab Concentrations During Induction Predict Time to Remission and Sustained Disease Control of Inflammatory Bowel Disease.
    Clin Res Hepatol Gastroenterol. 2024 May 13:102374.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

11. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
    Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient?Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2024 May 16. doi: 10.1007/s10620-024-08469.
    PubMed        
    
    
12. EMERSON C, Skvarc D, Mikocka-Walus A, Olive L, et al
    People with Inflammatory Bowel Disease Prefer Cognitive Behavioral Therapy for Fatigue Management: A Conjoint Analysis.
    Dig Dis Sci. 2024 May 11. doi: 10.1007/s10620-024-08468.
    PubMed         Abstract available
    
    
13. SIFFLEDEEN J, Singh S, Shulman SM, Igoe J, et al
    Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial.
    Dig Dis Sci. 2024;69:1636-1648.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

14. LOPEZ-SERRANO A, Cabaleiro AV, Ramon Lorente Montoro J, Gomez FJS, et al
    Artificial intelligence for dysplasia detection during surveillance colonoscopy in patients with ulcerative colitis: a cross-sectional, non-inferiority, diagnostic test comparison study.
    Gastroenterol Hepatol. 2024 May 11:502210. doi: 10.1016/j.gastrohep.2024.502210.
    PubMed         Abstract available
    
    

    
    Gut

15. MONAGHAN TM, Ugun-Klusek A, Finelli M, Gurnani P, et al
    Connecting inflammatory bowel and neurodegenerative diseases: microRNAs as a shared therapeutic intervention.
    Gut. 2024;73:1034-1036.
    PubMed        
    
    

    
    Inflamm Bowel Dis

16. THOMAS DM, Mundhra SK, Prasad S, Swaroop S, et al
    Combined or High Dose Immunosuppression in Inflammatory Bowel Disease patients who are NUDT15 Homozygous Harbors Risk of Developing Invasive Fungal Infections: A Case Series.
    Inflamm Bowel Dis. 2024 May 17:izae104. doi: 10.1093.
    PubMed        
    
    
17. ISHIKAWA D, Zhang X, Nomura K, Shibuya T, et al
    Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2024 May 11:izae080. doi: 10.1093.
    PubMed         Abstract available
    
    
18. DILLMAN JR, Tkach JA, Fletcher JG, Bruining DH, et al
    MRI and Blood-based Biomarkers Are Associated With Surgery in Children and Adults With Ileal Crohn's Disease.
    Inflamm Bowel Dis. 2024 May 13:izae101. doi: 10.1093.
    PubMed         Abstract available
    
    
19. BOHRA A, Van Langenberg DR
    Authors' Response to Letter to Editor: "Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status".
    Inflamm Bowel Dis. 2024 May 14:izae108. doi: 10.1093.
    PubMed        
    
    

    
    J Crohns Colitis

20. GIORDANO A, Rovira M, Veny M, Barastegui R, et al
    Cyclophosphamide-free mobilisation increases safety while preserving the efficacy of autologous haematopoietic stem cell transplantation in refractory Crohn's disease patients.
    J Crohns Colitis. 2024 May 17:jjae076. doi: 10.1093.
    PubMed         Abstract available
    
    
21. THOMANN AK, Schmitgen MM, Stephan JC, Ebert MP, et al
    Associations between brain morphology, inflammatory markers and symptoms of fatigue, depression or anxiety in active and remitted Crohn's disease.
    J Crohns Colitis. 2024 May 17:jjae078. doi: 10.1093.
    PubMed         Abstract available
    
    
22. KELLERMANN L, Hansen SL, Maciag G, Granau AM, et al
    Influence of vitamin D receptor signaling and vitamin D on colonic epithelial cell fate decisions in ulcerative colitis.
    J Crohns Colitis. 2024 May 15:jjae074. doi: 10.1093.
    PubMed         Abstract available
    
    
23. MONFORT-FERRE D, Boronat-Toscano A, Sanchez-Herrero JF, Caro A, et al
    Genome-wide DNA methylome and transcriptome profiling reveals key genes involved in the dysregulation of adipose-stem cells in Crohn's disease.
    J Crohns Colitis. 2024 May 15:jjae072. doi: 10.1093.
    PubMed         Abstract available
    
    
24. FUMERY M, Serrero M, Bouguen G, Amiot A, et al
    Real-world comparison of the effectiveness between ustekinumab and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent.
    J Crohns Colitis. 2024 May 14:jjae063. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

25. NAGANUMA M
    Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy".
    J Gastroenterol. 2024 May 13. doi: 10.1007/s00535-024-02113.
    PubMed        
    
    

    
    Lancet

26. LIBOW J
    The poetics of Crohn's disease.
    Lancet. 2024;403:1843.
    PubMed        
    
    

    
    Lancet Gastroenterol Hepatol

27. GUPTA A, Guisado D, Ricart E, Colombel JF, et al
    Haematopoietic stem-cell transplantation in Crohn's disease.
    Lancet Gastroenterol Hepatol. 2024;9:499-500.
    PubMed        
    
    
28. IACUCCI M, Santacroce G, Zammarchi I, Maeda Y, et al
    Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2024 May 14:S2468-1253(24)00053.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

29. CAMPO M, Hjelle H, Granlund AVB, Sandvik AK, et al
    The relationship between weight change and inflammatory bowel disease. A population-based cohort study, the HUNT study.
    Scand J Gastroenterol. 2024 May 13:1-5. doi: 10.1080/00365521.2024.2353099.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.